Volume 26, Number 3—March 2020
Dispatch
Progressive Vaccinia Acquired through Zoonotic Transmission in a Patient with HIV/AIDS, Colombia
Table
Sample date and type |
Serology |
PCR |
Viral culture |
||||
---|---|---|---|---|---|---|---|
IgM ELISA |
IgG ELISA |
Neutralization
titer |
OPXV-specific (Ct) |
Vaccinia-specific |
|||
2015 Mar | |||||||
Serum | Pos | Pos | 1:517 | ||||
Scab | Pos (31.9) | Pos | Pos | ||||
Scab |
Pos (28.6) |
Pos |
Pos |
||||
2015 Jul | |||||||
Serum | Neg | Pos | 1:223 | ||||
Scab, left leg | Pos (36.2) | Pos | Pos† | ||||
Swab, left leg |
Pos (29.2) |
Pos |
Pos† |
||||
2016 Apr | |||||||
Paraffin block, left leg | Neg | ||||||
Paraffin block, left leg | Neg | ||||||
Paraffin block, left leg | Neg |
*Ct, cycle threshold; Neg, negative; Pos, positive.
†Slow-growing.
1These authors contributed equally to this article.
Page created: February 20, 2020
Page updated: February 20, 2020
Page reviewed: February 20, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.